Eltrombopag in Second Line Adult Primary Immune Thrombosytopenia

Summary

A clinical study to evaluate the efficacy of a drug called eltrombopag in adult patients affected of primary immune thrombocytopenia as first treatment to address the disease.

Timeline

Start

2016-02-24

Primary completion

2018-05-22

Completion

2019-08-28

Drugs

Indications